在SCN1B相关发育性和性脑病变模型中改变了心脏刺激性和心律失常
Roberto Ramos-Mondragon1, Shuyun Wang1, Nnamdi Edokobi1
1Department of Pharmacology, The University of Michigan Medical School, Ann arbor, United States of America.
JCI insight
|August 5, 2025
概括
双性SCN1B变体导致DEE52,与SUDEP相关. 这项研究在小鼠和患者模型中发现了心脏电气和结构变化,表明心律失常会导致DEE52患者的SUDEP.
科学领域:
- 神经科学是一个神经科学.
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
背景情况:
- 在SCN1B基因中的双变异与发育性和性脑病变型52 (DEE52) 相关.
- DEE52呈现出严重和突然意外死亡 (SUDEP) 高风险.
- 在大脑和心脏中SCN1B基因表达表明潜在的心脏参与SUDEP.
研究的目的:
- 为了研究与DEE52相关的SCN1B变体 (Scn1b-c.265C>T) 的小鼠模型的心脏特征.
- 分析DEE52患者诱导的多能干细胞衍生的心肌细胞 (iPSC-CMs) 中的心脏功能.
- 探索与DEE52.52相关的SUDEP中心律不整的作用.
主要方法:
- 对Scn1b-c.265C>T同卵性小鼠的心脏表征.
- 来自DEE52患者的iPSC-CMs的电生理学评估,这些患者具有双 SCN1B-c.265C>T变异.
- 对小鼠心脏组织的组织学检查.
主要成果:
- Scn1bC89/C89小鼠表现出短暂增加的外向电流 (Ito) 密度和心室纤维化.
- 这些小鼠表现出对节奏诱导的心律失常的敏感性.
- 来自患者的iPSC-CM显示了增加的电流 (INa),晚期INa (INaL) 和Ito电流密度.
结论:
- 增加的Ito是在小鼠和人类DEE52模型中共享的心脏表型.
- 心脏中的电气和结构异常可能是导致DEE52.DEE中SUDEP的心律失常的原因.
相关概念视频
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
450
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
450


